Finance

Beta
Lists
OSTX:NYSEAMERICAN
OS Therapies Inc
$1.74
-2.79%
(-0.050) 1D
$1.76
+1.15% (+0.020)
After hours
Closed: Jun 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OSTX...
Open
$1.79
High
$1.84
Low
$1.71
Mkt. cap
77.50M
Avg. vol.
794.02K
Volume
0.00
52-wk high
$2.57
52-wk low
$1.15
EPS
-$1.05
Shares outstanding
44.54M
No. of employees
4
Open
$1.79
High
$1.84
Low
$1.71
Mkt. cap
77.50M
Avg. vol.
794.02K
Volume
0.00
52-wk high
$2.57
52-wk low
$1.15
EPS
-$1.05
Shares outstanding
44.54M
No. of employees
4
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to OSTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OSTX in the last 3 months.
Highest
Current $1.74
$13.00 (+647.13%)
Average
$9.50 (+445.98%)
Lowest
$6.00 (+244.83%)
News stories
From sources across the web
About OS Therapies Inc
CEO-
Employees4
Founded2018
HeadquartersRockville, Maryland, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.50M
3.76M
8.80M
7.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.34M
3.12M
3.19M
2.82M
Operating expense
4.84M
6.88M
11.99M
10.17M
Total operating expenses
4.84M
6.88M
11.99M
10.17M
Operating income
-4.84M
-6.88M
-11.99M
-10.17M
Other non operating income
302.04K
-
-1.47M
-153.59K
EBT including unusual items
-4.54M
-6.88M
-13.46M
-10.40M
EBT excluding unusual items
-4.54M
-6.88M
-13.46M
-10.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.54M
-6.88M
-13.46M
-10.40M
Net profit margin
-
-
-
-
Earnings per share
-0.19
-0.21
-0.41
-0.27
Interest and investment income
64.00
65.00
54.00
45.00
Interest expense
-
-
-
-75.34K
Net interest expenses
64.00
65.00
54.00
-75.30K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.73M
-6.75M
-11.86M
-10.04M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more